Related Experiment Video
Updated: May 9, 2026
11:29
Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
Published on: August 15, 2025
Prognostic factors for medically intractable epilepsy: a systematic review
Merel Wassenaar1, Frans S S Leijten, Toine C G Egberts
1Department of Neurology and Neurosurgery, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, The Netherlands; SEIN-Epilepsy Institute in the Netherlands Foundation, Heemstede, The Netherlands.
Epilepsy Research
|July 25, 2013
Summary
Identifying early predictors for medically intractable epilepsy is crucial. While factors like younger age at onset and seizure frequency show promise, consistent evidence is lacking, necessitating further research.
Area of Science:
- Neurology
- Epileptology
- Clinical Epidemiology
Background:
- One-third of epilepsy patients experience medically intractable epilepsy.
- Early identification of prognostic factors can improve patient management.
- This review synthesizes evidence on predictors of epilepsy intractability.
Purpose of the Study:
- To systematically review prognostic factors for medically intractable epilepsy.
- To identify factors that predict treatment resistance in epilepsy patients.
Main Methods:
- Systematic review of MEDLINE and EMBASE databases.
- Included 11 cohort studies, assessing quality using the QUIPS checklist.
- Summarized independent prognostic factors reported in individual studies.
Main Results:
- Younger age at onset, symptomatic etiology, high seizure frequency, medical history, EEG abnormalities, and prior antiepileptic drug (AED) failure were identified as potential prognostic factors.
- No single factor was consistently reported across all studies.
- Studies were of moderate quality and lacked consideration of genetic, neurobiological, or immunological factors.
Conclusions:
- Evidence for prognostic factors of medically intractable epilepsy is inconsistent.
- There is a need for high-quality, population-based cohort studies.
- Future research should incorporate genetic, neurobiological, and immunological factors for improved prediction models.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:13Seizures: Classification
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...